These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

765 related items for PubMed ID: 23870158

  • 1. Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant?
    Tandberg DJ, Gee NG, Chino JP, D'Amico TA, Ready NE, Coleman RE, Kelsey CR.
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):796-801. PubMed ID: 23870158
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2/N3 node-negative non-small cell lung cancer.
    Trister AD, Pryma DA, Xanthopoulos E, Kucharczuk J, Sterman D, Rengan R.
    Am J Clin Oncol; 2014 Apr; 37(2):135-9. PubMed ID: 23111361
    [Abstract] [Full Text] [Related]

  • 4. False-positivity of mediastinal lymph nodes has negative effect on survival in potentially resectable non-small cell lung cancer.
    Iskender I, Kadioglu SZ, Cosgun T, Kapicibasi HO, Sagiroglu G, Kosar A, Kir A.
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):874-9. PubMed ID: 22423060
    [Abstract] [Full Text] [Related]

  • 5. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.
    Al-Sarraf N, Aziz R, Gately K, Lucey J, Wilson L, McGovern E, Young V.
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738
    [Abstract] [Full Text] [Related]

  • 6. Non-small cell lung cancer: prognostic importance of positive FDG PET findings in the mediastinum for patients with N0-N1 disease at pathologic analysis.
    Xie L, Saynak M, Veeramachaneni NK, Fried DV, Jagtap MR, Chiu WK, Higginson DS, Lawrence MV, Khandani AH, Qaqish BF, Chen RC, Marks LB.
    Radiology; 2011 Oct; 261(1):226-34. PubMed ID: 21813742
    [Abstract] [Full Text] [Related]

  • 7. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
    Miyasaka Y, Suzuki K, Takamochi K, Matsunaga T, Oh S.
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
    [Abstract] [Full Text] [Related]

  • 8. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, Erelel M, Ece T, Mudun A.
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [Abstract] [Full Text] [Related]

  • 9. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
    Sivrikoz CM, Ak I, Simsek FS, Döner E, Dündar E.
    Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019
    [Abstract] [Full Text] [Related]

  • 10. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
    Lin JT, Yang XN, Zhong WZ, Liao RQ, Dong S, Nie Q, Weng SX, Fang XJ, Zheng JY, Wu YL.
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
    [Abstract] [Full Text] [Related]

  • 11. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
    Hu M, Yu JM, Liu NB, Liu LP, Guo HB, Yang GR, Zhang PL, Xu XQ.
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):306-9. PubMed ID: 18788639
    [Abstract] [Full Text] [Related]

  • 12. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?
    Hellwig D, Graeter TP, Ukena D, Groeschel A, Sybrecht GW, Schaefers HJ, Kirsch CM.
    J Nucl Med; 2007 Nov; 48(11):1761-6. PubMed ID: 17942814
    [Abstract] [Full Text] [Related]

  • 13. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X, Zheng L, Zhang SY, Xie ZM, Yu H, Su XD, Wang JY, Huang ZF, Yang MT, Rong TH.
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic Accuracy of Mediastinal Lymph Node Staging Techniques in the Preoperative Assessment of Nonsmall Cell Lung Cancer Patients.
    Fréchet B, Kazakov J, Thiffault V, Ferraro P, Liberman M.
    J Bronchology Interv Pulmonol; 2018 Jan; 25(1):17-24. PubMed ID: 29261576
    [Abstract] [Full Text] [Related]

  • 15. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
    Li X, Zhang H, Xing L, Xu X, Xie P, Ma H, Zhang L, Chen M, Sun X, Xu W, Chen L, Yu J.
    Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
    [Abstract] [Full Text] [Related]

  • 16. Combined Endosonographic Mediastinal Lymph Node Staging in Positron Emission Tomography and Computed Tomography Node-Negative Non-Small-Cell Lung Cancer in High-Risk Patients.
    Hegde P, Molina JC, Thivierge-Southidara M, Jain RV, Gowda A, Ferraro P, Liberman M.
    Semin Thorac Cardiovasc Surg; 2020 Sep; 32(1):162-168. PubMed ID: 31325576
    [Abstract] [Full Text] [Related]

  • 17. Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer.
    Perigaud C, Bridji B, Roussel JC, Sagan C, Mugniot A, Duveau D, Baron O, Despins P.
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):731-6. PubMed ID: 19632852
    [Abstract] [Full Text] [Related]

  • 18. FDG-PET parameters predicting mediastinal malignancy in lung cancer.
    Serra Fortuny M, Gallego M, Berna L, Montón C, Vigil L, Masdeu MJ, Fernández-Villar A, Botana MI, Cordovilla R, García-Luján R, Cases E, Monsó E.
    BMC Pulm Med; 2016 Dec 08; 16(1):177. PubMed ID: 27931198
    [Abstract] [Full Text] [Related]

  • 19. Fusion positron emission/computed tomography underestimates the presence of hilar nodal metastases in patients with resected non-small cell lung cancer.
    Carrillo SA, Daniel VC, Hall N, Hitchcock CL, Ross P, Kassis ES.
    Ann Thorac Surg; 2012 May 08; 93(5):1621-4. PubMed ID: 22429676
    [Abstract] [Full Text] [Related]

  • 20. Prognosis of unexpected and expected pathologic N1 non-small cell lung cancer.
    Shin S, Kim HK, Choi YS, Kim K, Kim J, Shim YM.
    Ann Thorac Surg; 2013 Sep 08; 96(3):969-75; discussion 975-6. PubMed ID: 23916803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.